- Home
- CREX vs TPST Comparison
CREX vs TPST Comparison
Compare CREX & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREX
- TPST
- Stock Information
- Founded
- CREX N/A
- TPST 2011
- Country
- CREX United States
- TPST United States
- Employees
- CREX N/A
- TPST N/A
- Industry
- CREX EDP Services
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- CREX Technology
- TPST Health Care
- Exchange
- CREX Nasdaq
- TPST Nasdaq
- Market Cap
- CREX 33.5M
- TPST 33.0M
- IPO Year
- CREX N/A
- TPST N/A
- Fundamental
- Price
- CREX $3.24
- TPST $7.06
- Analyst Decision
- CREX Strong Buy
- TPST Hold
- Analyst Count
- CREX 1
- TPST 3
- Target Price
- CREX $6.00
- TPST $30.00
- AVG Volume (30 Days)
- CREX 156.9K
- TPST 245.0K
- Earning Date
- CREX 08-13-2025
- TPST 08-07-2025
- Dividend Yield
- CREX N/A
- TPST N/A
- EPS Growth
- CREX N/A
- TPST N/A
- EPS
- CREX N/A
- TPST N/A
- Revenue
- CREX $48,303,000.00
- TPST N/A
- Revenue This Year
- CREX $10.03
- TPST N/A
- Revenue Next Year
- CREX $18.84
- TPST N/A
- P/E Ratio
- CREX N/A
- TPST N/A
- Revenue Growth
- CREX 1.68
- TPST N/A
- 52 Week Low
- CREX $1.28
- TPST $5.35
- 52 Week High
- CREX $5.20
- TPST $30.03
- Technical
- Relative Strength Index (RSI)
- CREX 56.12
- TPST 49.91
- Support Level
- CREX $3.00
- TPST $6.87
- Resistance Level
- CREX $3.46
- TPST $7.25
- Average True Range (ATR)
- CREX 0.34
- TPST 0.67
- MACD
- CREX -0.08
- TPST -0.02
- Stochastic Oscillator
- CREX 35.00
- TPST 11.20
About CREX Creative Realities Inc.
Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.